Ohio radiologist says AI won't wipe out the profession anytime soon

Plenty of warnings have been offered about radiology's impending doom thanks to artificial intelligence (AI). Phil Shaffer, a radiologist at Riverside Radiology and Interventional Associates in Columbus, Ohio, offered a response with an opinion piece published in The Scientist.

Largely responding to a June 25 opinion piece predicting an AI takeover also published in The Scientist, Shaffer argued that many do not understand radiologists do more than identify spots on an x-ray. Even the most sophisticated algorithms lack the ability to inject context into readings—a key trait that helps define what it means to be a radiologist, he argued.

Shaffer also warned against falling for the newest, intoxicating technology that often does not perform as well as marketed. He believes radiologists need to be skeptical of entrepreneurs and work proactively with those creating AI. 

“Radiologists should, and will, guide the deployment of advanced software tools,” wrote Shaffer in opinion piece. “This should not be done by entrepreneurs who have no experience applying new technologies to patient care. We should avoid credulous acceptance of AI for medical imaging and demand extensive proof before unleashing it on the public.”

Read the entire story below.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.